TOP STORIES

• ORGANIZATION Global Pharma CEOs Prod Japan to Keep Pro-Innovation Policy, Sound Alarm on Proposed PMP Review
  October 31, 2017

• REGULATORY Opdivo Could Face Deeper Cut with Revision of Dosage-Change Re-Pricing Rule; Keytruda Could Be Affected Too
  October 30, 2017

• REGULATORY CEFP Kicks Off FY2018 Budget Debate with Major Focus on Scope of Off-Year Price Survey, Revision
  October 27, 2017

• REGULATORY Payer Rep Insists CEA-Based Price Hike “Not an Option,” MHLW Wants “Grounds” for That Argument: Chuikyo
  October 26, 2017

• REGULATORY Sanofi’s Dupilumab, Chugai’s PD-L1 Inhibitor and More Up for MHLW Panel Review on Nov. 6
  October 25, 2017

• ACADEMIA Japan’s 1st Constipation Treatment Guidelines Recommend Drugs Acting on Epithelial Function Including Amitiza
  October 25, 2017

• INTERVIEW Takeda Eager to Build Life Science Hub in Shonan, Offer Research Environment Akin to US East Coast: Exec Hirate
  October 24, 2017

• BUSINESS Mitsubishi Tanabe to Focus on US Approval for VLP Seasonal Flu Vaccine; Aims at 100 Billion Yen Sales for Vaccine Business by FY2030
  October 24, 2017

• REGULATORY Japan Introduction of GDP Likely to Begin with Guideline that Calls on Companies to Make “Good Faith Effort”: MHLW Study Group
  October 23, 2017

• BUSINESS LEO Pharma Japan to Set Up Stand-Alone Sales Force in 5 Years, Eyes 100 Reps
  October 20, 2017

• REGULATORY Price Maintenance Premium, Z2 Reduction Rates under Attack by CEFP Working Group
  October 19, 2017

• REGULATORY National Database Initiative for Regenerative Medicine Goes Live; Use for Review, Development Eyed
  October 18, 2017

• BUSINESS Nobelpharma Plans to File Sakigake-Designated Topical Sirolimus; Application Expected Later this Month
  October 17, 2017

• BUSINESS Takeda Looks to House 3,000 Researchers at Shonan Innovation Park, Create Fund by March
  October 16, 2017

• ACADEMIA Nephrology Society to Build Database, Biobank to Support Drug Discovery; Some 20 Companies Interested in Collaboration
  October 13, 2017

• REGULATORY FPMAJ Chief Trades Barbs with Chuikyo Payer Rep, Says Western-Style HTA Doesn’t Fit Japan’s Unique Market Mechanism
  October 12, 2017

• REGULATORY Any CEA-Based Price Adjustment Must Be Limited to Premium Rates: 3 Pharma Groups
  October 11, 2017

• REGULATORY MHLW to Issue Basic Guide to PMS for Conditional Early Approval: Drug Review Chief
  October 11, 2017

• REGULATORY Japan Needs “Quick and Low-Cost” R&D Setup: Top MD Bureaucrat
  October 10, 2017

• REGULATORY MHLW to Place Priority on “Mutual Understanding” with Industry: Economic Affairs Chief
  October 6, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• …
• Next ›
• 最終 »